Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q1 2020 · 10-Q
Revenue$3.12M$3.12M+26.0% vs Q1 2019 Net Income-$2.06M-$2.06MN/M vs Q1 2019 EPS Diluted-$0.13-$0.13N/M vs Q1 2019 Operating Income-$1,209,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Margins · derivedOperating margin-38.8%+0.5 pt vs Q1 2019
Net margin-65.9%−16.6 pt vs Q1 2019
ended Mar 31, 2020 · filed May 13, 2020 · 43 d after period end